Jpmorgan Chase & CO Biomea Fusion, Inc. Transaction History

Jpmorgan Chase & CO

$1.23 Trillion
Q4 2024

A detailed history of Jpmorgan Chase & CO transactions in Biomea Fusion, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 22,535 shares of BMEA stock, worth $77,971. This represents 0.0% of its overall portfolio holdings.

Number of Shares

22,535

Previous 17,667 27.55%

Holding current value

$77,971

Previous $178,000 51.12%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$3.88 - $12.41 $18,887 - $60,411	4,868 Added 27.55%	22,535 $87,000
Q3 2024 Dec 26, 2024	SELL	$4.23 - $10.1 $1,649 - $3,939	-390 Reduced 2.16%	17,667 $178,000
Q3 2024 Nov 08, 2024	SELL	$4.23 - $10.1 $1,649 - $3,939	-390 Reduced 2.16%	17,667 $178,000
Q2 2024 Dec 26, 2024	BUY	$4.14 - $15.3 $1,614 - $5,967	390 Added 2.21%	18,057 $81,000
Q2 2024 Aug 12, 2024	SELL	$4.14 - $15.3 $23,771 - $87,852	-5,742 Reduced 24.13%	18,057 $81,000
Q1 2024 Dec 26, 2024	BUY	$13.92 - $19.5 $85,357 - $119,574	6,132 Added 34.71%	23,799 $355,000
Q1 2024 May 10, 2024	SELL	$13.92 - $19.5 $47,982 - $67,216	-3,447 Reduced 12.65%	23,799 $355,000
Q4 2023 Dec 26, 2024	BUY	$8.37 - $19.8 $80,176 - $189,664	9,579 Added 54.22%	27,246 $395,000
Q4 2023 Feb 12, 2024	SELL	$8.37 - $19.8 $1.03 Million - $2.44 Million	-123,141 Reduced 81.88%	27,246 $395,000
Q3 2023 Nov 14, 2023	BUY	$13.44 - $23.02 $138,270 - $236,829	10,288 Added 7.34%	150,387 $2.07 Million
Q2 2023 Aug 11, 2023	SELL	$21.66 - $41.8 $537,168 - $1.04 Million	-24,800 Reduced 15.04%	140,099 $3.08 Million
Q1 2023 May 11, 2023	SELL	$6.8 - $32.35 $237,408 - $1.13 Million	-34,913 Reduced 17.47%	164,899 $5.11 Million
Q4 2022 Feb 13, 2023	SELL	$6.3 - $11.6 $184,067 - $338,917	-29,217 Reduced 12.76%	199,812 $1.68 Million
Q3 2022 Nov 14, 2022	SELL	$9.51 - $13.61 $426,960 - $611,034	-44,896 Reduced 16.39%	229,029 $2.24 Million
Q2 2022 Aug 11, 2022	BUY	$3.0 - $12.03 $769,629 - $3.09 Million	256,543 Added 1475.91%	273,925 $3.28 Million
Q1 2022 May 11, 2022	BUY	$4.39 - $9.03 $12,182 - $25,058	2,775 Added 19.0%	17,382 $77,000
Q4 2021 Feb 10, 2022	BUY	$7.22 - $12.72 $55,702 - $98,134	7,715 Added 111.94%	14,607 $109,000
Q3 2021 Nov 12, 2021	BUY	$10.0 - $15.99 $68,920 - $110,203	6,892 New	6,892 $83,000

Others Institutions Holding BMEA

# of Institutions

126

Shares Held

17.5M

Call Options Held

1.8M

Put Options Held

1.08M

View Full List

About Biomea Fusion, Inc.

Ticker BMEA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,290,600
Market Cap $101M
Description
Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...

More about BMEA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Biomea Fusion, Inc. Transaction History